Vascular smooth muscle cells and calcification in atherosclerosis

American Heart Journal

Volumn 147, Issue 5, 2004, Pages 808-814

  Trion, Astrid ^a   Van Der Laarse, Arnoud ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; LIPID; OSTEOCALCIN; OSTEONECTIN; PHOSPHATE;

APOPTOSIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE MATRIX; BONE MINERALIZATION; BONE TISSUE; CELL INTERACTION; HUMAN; MACROPHAGE; MEMBRANE VESICLE; NONHUMAN; OSSIFICATION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 3042733616     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.10.047     Document Type: Article

References (49)

1. McGill H.C. Overview. Fuster V., Ross R., Topol E.J. Atherosclerosis and coronary artery disease. 1996;25-41 Lippincott-Raven, Philadelphia
2. Topol E.J., Nissen S.E. Our preoccupation with coronary luminology the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 92:1995;2333-2342
3. Glagov S., Weisenberg E., Zarins C.K., et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 316:1987;1371-1375
4. Little W.C., Constantinescu M., Applegate R.J., et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 78:1988;1157-1166
5. Raggi P., Callister T.Q., Cooil B., et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 101:2000;850-855
6. Raggi P., Cooil B., Callister T.Q. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J. 141:2001;375-382
7. Detrano R.C., Wong N.D., Doherty T.M., et al. Prognostic significance of coronary calcific deposits in asymptomatic high-risk subjects. Am J Med. 102:1997;344-349
8. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 314:1986;488-500
9. Schwartz S.M., Campbell G.R., Campbell J.H. Replication of smooth muscle cells in vascular disease. Circ Res. 58:1986;427-444
10. Berk B.C. Vascular smooth muscle growth autocrine growth mechanisms. Physiol Rev. 81:2001;999-1030
11. Aikawa M., Sivam P.N., Kuro-o M., et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 73:1993;1000-1012
12. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 75:1995;487-517
13. Lemire J.M., Covin C.W., White S., et al. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol. 144:1994;1068-1081
14. Hao H., Ropraz P., Verin V., et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol. 22:2002;1093-1099
15. Thomas A.C., Campbell J.H. Smooth muscle cells of injured rat and rabbit arteries in culture contractile and cytoskeletal proteins. Atherosclerosis. 154:2001;291-299
16. Watson K.E., Bostrom K., Ravindranath R., et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 93:1994;2106-2113
17. Bostrom K., Watson K.E., Horn S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 91:1993;1800-1809
18. Mohler E.R. III, Gannon F., Reynolds C., et al. Bone formation and inflammation in cardiac valves. Circulation. 103:2001;1522-1528
19. Kockx M.M., De Meyer G.R., Muhring J., et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 97:1998;2307-2315
20. Anderson H.C. Calcific diseases a concept. Arch Pathol Lab Med. 107:1983;341-348
21. Doherty M.J., Ashton B.A., Walsh S., et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 13:1998;828-838
22. Giachelli C.M., Bae N., Almeida M., et al. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 92:1993;1686-1696
23. O'Brien E.R., Garvin M.R., Stewart D.K., et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 14:1994;1648-1656
24. Shanahan C.M., Proudfoot D., Tyson K.L., et al. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z Kardiol. 89:(Suppl 2):2000;63-68
25. Shanahan C.M., Cary N.R., Metcalfe J.C., et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 93:1994;2393-2402
26. Dhore C.R., Cleutjens J.P., Lutgens E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 21:2001;1998-2003
27. Anderson H.C. Molecular biology of matrix vesicles. Clin Orthop. 314:1995;266-280
28. Proudfoot D., Skepper J.N., Shanahan C.M., et al. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol. 18:1998;379-388
29. Proudfoot D., Skepper J.N., Hegyi L., et al. Apoptosis regulates human vascular calcification in vitro evidence for initiation of vascular calcification by apoptotic bodies. Circ Res. 87:2000;1055-1062
30. Tintut Y., Patel J., Parhami F., et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 102:2000;2636-2642
31. Jono S., Nishizawa Y., Shioi A., et al. 1, 25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 98:1998;1302-1306
32. Tintut Y., Patel J., Territo M., et al. Monocyte/macrophage regulation of vascular calcification in vitro. Circulation. 105:2002;650-655
33. Parhami F., Tintut Y., Patel J.K., et al. Regulation of vascular calcification in atherosclerosis. Z Kardiol. 90:(Suppl 3):2001;27-30
34. Boyle J.J., Bowyer D.E., Weissberg P.L., et al. Human blood-derived macrophages induce apoptosis in human plaque-derived vascular smooth muscle cells by Fas-ligand/Fas interactions. Arterioscler Thromb Vasc Biol. 21:2001;1402-1407
35. Towler D.A., Bidder M., Latifi T., et al. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem. 273:1998;30427-30434
36. Shen M., Kara-Mostefa A., Chen L., et al. Effect of ethanol and ether in the prevention of calcification of bioprostheses. Ann Thorac Surg. 71:2001;S413-416
37. Holvoet P., Vanhaecke J., Janssens S., et al. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 98:1998;1487-1494
38. Parhami F., Morrow A.D., Balucan J., et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 17:1997;680-687
39. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification Circ Res. 87:2000;E10-17
40. Shioi A., Mori K., Jono S., et al. Mechanism of atherosclerotic calcification. Z Kardiol. 89:(Suppl 2):2000;75-79
41. Meleti Z., Shapiro I.M., Adams C.S. Inorganic phosphate induces apoptosis of osteoblast-like cells in culture. Bone. 27:2000;359-366
42. Huang H., Virmani R., Younis H., et al. The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation. 103:2001;1051-1056
43. Zhao X.Q., Yuan C., Hatsukami T.S., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI a case-control study. Arterioscler Thromb Vasc Biol. 21:2001;1623-1629
44. Libby P., Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs. 56:(Suppl 1):1998;9-13
45. Vaughan C.J., Gotto A.M. Jr, Basson C.T. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol. 35:2000;1-10
46. Brown B.G., Zhao X.Q., Sacco D.E., et al. Lipid lowering and plaque regression new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation. 87:1993;1781-1791
47. Hunt J.L., Fairman R., Mitchell M.E., et al. Bone formation in carotid plaques a clinicopathological study. Stroke. 33:2002;1214-1219
48. Mathiesen E.B., Bonaa K.H., Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis the Tromsø study. Circulation. 103:2001;2171-2175
49. Davies M.J., Richardson P.D., Woolf N., et al. Risk of thrombosis in human atherosclerotic plaques role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J. 69:1993;377-381